The efficacy & safety of various doses of fulranumab vs placebo for chronic LBP

Clin Ther. 2016 Jun;38(6):1435-50

OARSI 2016: Glucosamine and chondroitin not more effective than placebo for knee OA

Hyaluronic acid injection similar in symptom & structure of knee OA vs diacerein & placebo

Ann Rheum Dis. 2004 Dec;63(12):1611-7

Capsaicin provide comparable or better pain and functional improvement than placebo

Clin Drug Investig. 2011 Dec 1;31(12):877-82. doi: 10.2165/11593860-000000000-00000

Glucosamine + chondroitin reduced joint space narrowing at 2 years vs. placebo in knee OA

Ann Rheum Dis. 2015 May;74(5):851-8.

Chrondroitin sulfate improves pain and function compared to placebo in the management of knee OA

Ann Rheum Dis. 2017 May 22. pii: annrheumdis-2016-210860. doi: 10.1136/annrheumdis-2016-210860. [Epub ahead of print]

Single-dose intra-articular bupivacaine significantly reduces pain after knee arthroscopy

Knee Surg Sports Traumatol Arthrosc. 2014 Jul;22(7):1517-28

AAOS 2016: High-dose hyaluronate reduces pain versus placebo for plantar fasciitis

Dronabinol increases pain threshold compared to placebo for functional chest pain over 4 weeks

Dis Esophagus. 2017 Feb 1;30(2):1-8. doi: 10.1111/dote.12455

WCO-IOF: Dynamic electroneurostimulation vs placebo for osteoporotic spine fractures

Titrated THC:CBD Improves Pain and Spasticity Compared to Placebo Over 12 Weeks for Resistant MS

Int J Neurosci. 2018 Sep 13:1-10.

Celecoxib and naproxen beneficial in Asian patients with knee OA compared to a placebo

Int J Rheum Dis. 2016 Mar;19(3):262-70

WCO-IOF 2016: Lasofoxifene, raloxifene, and placebo for BMD in postmenopausal women

Nabiximols improves multiple sclerosis spasticity compared to placebo over 12 weeks

Eur J Neurol. 2011 Sep;18(9):1122-31. doi: 10.1111/j.1468-1331.2010.03328.x

AAOS: Hyaluronic acid and placebo produce similar pain and functional outcomes for knee OA

Comparable efficacy with etoricoxib 30mg and ibuprofen 2400mg in treating hip or knee OA

Osteoarthritis Cartilage. 2007 Dec;15(12):1348-56. Epub 2007 Jul 16

Delta 9-THC has better analgesic efficacy versus placebo for neuropathic pain over 6 hours

J Pain. 2008 Jun;9(6):506-21. doi: 10.1016/j.jpain.2007.12.010

Oral tetrahydrocannabinol (THC) does not reduce chronic abdominal pain compared to placebo

Clin Gastroenterol Hepatol. 2017 Jul;15(7):1079-1086.e4. doi: 10.1016/j.cgh.2016.09.147

Delta-9 THC Improves Pain and Spasticity Compared to Placebo for Multiple Sclerosis Over 2 Weeks

CMAJ. 2012 Jul 10;184(10):1143-50. https://dx.doi.org/10.1503/cmaj.110837

THC/CBD oromucosal spray is not better than placebo for diabetic neuropathy over 12 weeks

Diabetes Care. 2010 ;33(1):128-130. http://dx.doi.org/10.2337/dc09-1029